Mikkel Bring Christensen

Mikkel Bring Christensen

Clinical Professor

Member of:

  • Clinical Pharmacology


Publication year:
All
1 - 28 out of 28Page size: 500
  1. 2020
  2. Published

    Total burden of disease in cancer patients at diagnosis—a Danish nationwide study of multimorbidity and redeemed medication

    Loeppenthin, K., Dalton, Susanne Oksbjerg, Johansen, Christoffer, Andersen, E., Christensen, Mikkel Bring, Pappot, Helle, Petersen, L. N., Thisted, L. B., Frølich, A., Mortensen, C. E., Lassen, Ulrik Niels, Ørsted, J. & Bidstrup, P. E., 15 Sep 2020, In: British Journal of Cancer. 123, 6, p. 1033-1040 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Medication-related experiences of patients with polypharmacy: a systematic review of qualitative studies

    Eriksen, C. U., Kyriakidis, S., Christensen, L. D., Jacobsen, Ramune, Laursen, J., Christensen, Mikkel Bring & Frølich, Anne, 6 Sep 2020, In: BMJ Open. 10, 9, 11 p., e036158.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Clinical pharmacology of imeglimin for the treatment of type 2 diabetes

    Johansson, K. S., Brønden, A., Knop, Filip Krag & Christensen, Mikkel Bring, May 2020, In: Expert Opinion on Pharmacotherapy. 21, 8, p. 871-882

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    GIP's involvement in the pathophysiology of type 2 diabetes

    Christensen, Mikkel Bring, Gasbjerg, Lærke Smidt, Heimbürger, S. M., Stensen, S., Vilsbøll, Tina & Knop, Filip Krag, Mar 2020, In: Peptides. 125, 10 p., 170178.

    Research output: Contribution to journal › Review › Research › peer-review

  6. Published

    Glycemic control and use of glucose-lowering medications in hospital-admitted type 2 diabetes patients over 80 years

    Gotfredsen, D. R., Vinther, S., Petersen, Tonny Studsgaard, Cortes, R., Jensen, T. B., Solem, Espen Victor Jimenez & Christensen, Mikkel Bring, Mar 2020, In: Scientific Reports. 10, 8 p., 4095.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Cardiovascular effects of high-dose glucagon: a randomised clinical trial

    Petersen, K. M., Bogevig, S., Riis, T., Andersson, N. A. W., Dalhoff, Kim, Holst, Jens Juul, Knop, Filip Krag, Faber, Jens, Petersen, Tonny Studsgaard & Christensen, Mikkel Bring, 2020, In: Diabetologia. 63, SUPPL 1, p. S231-S231

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  8. Published

    Evaluation of the incretin effect in humans using GIP and GLP-1 receptor antagonists

    Gasbjerg, Lærke Smidt, Bergmann, N. C., Stensen, S., Christensen, Mikkel Bring, Rosenkilde, Mette, Holst, Jens Juul, Nauck, M. & Knop, Filip Krag, 2020, In: Peptides. 125, 10 p., 170183.

    Research output: Contribution to journal › Review › Research › peer-review

  9. Published

    GIP and GLP-1 Receptor Antagonism During a Meal in Healthy Individuals

    Gasbjerg, Lærke Smidt, Helsted, M. M., Hartmann, Bolette, wbf943, wbf943, Veedfald, Simon, Stensen, S., Lanng, A. R., Bergmann, N. C., Christensen, Mikkel Bring, Vilsbøll, Tina, Holst, Jens Juul, Rosenkilde, Mette & Knop, Filip Krag, 2020, In: Journal of Clinical Endocrinology and Metabolism. 105, 3, p. e725-e738 14 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    GIP and the gut-bone axis – Physiological, pathophysiological and potential therapeutic implications

    Stensen, S., Gasbjerg, Lærke Smidt, Helsted, M. M., Hartmann, Bolette, Christensen, Mikkel Bring & Knop, Filip Krag, 2020, In: Peptides. 125, 7 p., 170197.

    Research output: Contribution to journal › Review › Research › peer-review

  11. Published

    GIP infusion in patients with type 1 diabetes seems to attenuate post-prandial glucose excursions after prandial insulin over-dose and physical activity

    Hoe, B., Heimburger, S. M. N., Gasbjerg, L. S., Lanng, A. R., Lynggaard, M. B., Hartmann, Bolette, Holst, Jens Juul, Vilsbøll, Tina, Lund, A., Engberg, S., Dejgaard, T. F., Christensen, Mikkel Bring & Knop, Filip Krag, 2020, In: Diabetologia. 63, Suppl. 1, p. S117 1 p., 232.

    Research output: Contribution to journal › Conference abstract in journal › Research

  12. Published

    GIP's effect on bone metabolism is reduced by the selective GIP receptor antagonist GIP(3-30)NH2

    Gasbjerg, Lærke Smidt, Hartmann, Bolette, Christensen, Mikkel Bring, Lanng, A. R., Vilsbøll, Tina, Jørgensen, Niklas Rye, Holst, Jens Juul, Rosenkilde, Mette & Knop, Filip Krag, 2020, In: Bone. 130, 6 p., 115079 .

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    GIP(3-30)NH2 – a tool for the study of GIP physiology

    Lynggaard, M. B., Gasbjerg, Lærke Smidt, Christensen, Mikkel Bring & Knop, Filip Krag, 2020, In: Current Opinion in Pharmacology. 55, p. 31-40 10 p.

    Research output: Contribution to journal › Review › Research › peer-review

  14. Published

    Glucagon-like peptide-1 receptor regulation of basal dopamine transporter activity is species-dependent

    Jensen, M. E., Galli, A., Thomsen, M., Jensen, Kathrine Louise, Thomsen, G. K., Klausen, M. K., Vilsbøll, Tina, Christensen, Mikkel Bring, Holst, Jens Juul, Owens, A., Robertson, S., Daws, L., Zanella, D., Gether, Ulrik, Knudsen, Gitte Moos & Fink-Jensen, Anders, 2020, In: Neurochemistry International. 138, 9 p., 104772.

    Research output: Contribution to journal › Journal article › Research › peer-review

  15. Published

    Glucose-Dependent Insulinotropic Polypeptide (GIP) Reduces Bone Resorption in Patients With Type 2 Diabetes

    Christensen, Mikkel Bring, Lund, A. B., Jørgensen, Niklas Rye, Holst, Jens Juul, Vilsbøll, Tina & Knop, Filip Krag, 2020, In: Journal of the endocrine society. 4, 9, 9 p., 097.

    Research output: Contribution to journal › Journal article › Research › peer-review

  16. Published

    Glucose-Dependent Insulinotropic Polypeptide Is a Pancreatic Polypeptide Secretagogue in Humans

    Veedfald, Simon, Vedtofte, L., Skov-Jeppesen, Kirsa, Deacon, Carolyn F., Hartmann, Bolette, Vilsbøll, Tina, Knop, Filip Krag, Christensen, Mikkel Bring & Holst, Jens Juul, 2020, In: Journal of Clinical Endocrinology and Metabolism. 105, 3, p. e502-e510

    Research output: Contribution to journal › Journal article › Research › peer-review

  17. Published

    Glucose-dependent insulinotropic polypeptide (GIP) and cardiovascular disease

    Heimbürger, S. M., Bergmann, N. C., Augustin, R., Gasbjerg, Lærke Smidt, Christensen, Mikkel Bring & Knop, Filip Krag, 2020, In: Peptides. 125, 8 p., 170174.

    Research output: Contribution to journal › Review › Research › peer-review

  18. Published

    Glycaemic variability and hypoglycaemia are associated with C-peptide levels in insulin-treated type 2 diabetes

    Christensen, Mikkel Bring, Gæde, P., Hommel, E., Gotfredsen, A. & Nørgaard, K., 2020, In: Diabetes and Metabolism. 46, 1, p. 61-65

    Research output: Contribution to journal › Journal article › Research › peer-review

  19. Published

    High-Dose Glucagon Has Hemodynamic Effects Regardless of Cardiac Beta-Adrenoceptor Blockade: A Randomized Clinical Trial

    Petersen, K. M., Bøgevig, S., Riis, T., Andersson, N. W., Dalhoff, Kim, Holst, Jens Juul, Knop, Filip Krag, Faber, Jens, Petersen, Tonny Studsgaard & Christensen, Mikkel Bring, 2020, In: Journal of the American Heart Association. 9, 21, 27 p., e016828.

    Research output: Contribution to journal › Journal article › Research › peer-review

  20. Published

    Multidisciplinær håndtering af svær jernforgiftning som følge af suicidalforsøg

    Petersen, S. M., jfn630, jfn630, Svane, M. S. & Christensen, Mikkel Bring, 2020, In: Ugeskrift for Laeger. 182, 46

    Research output: Contribution to journal › Letter › Research › peer-review

  21. Published

    No Acute Effects of Exogenous Glucose-Dependent Insulinotropic Polypeptide on Energy Intake, Appetite, or Energy Expenditure When Added to Treatment With a Long-Acting Glucagon-Like Peptide 1 Receptor Agonist in Men With Type 2 Diabetes

    Bergmann, N. C., Gasbjerg, Lærke Smidt, Heimbürger, S. M., Krogh, L. S. L., Dela, Flemming, Hartmann, Bolette, Holst, Jens Juul, Jessen, L., Christensen, Mikkel Bring, Vilsbøll, Tina, Lund, A. & Knop, Filip Krag, 2020, In: Diabetes Care. 43, 3, p. 588-596 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  22. Published

    Patient experiences of polypharmacy: a systematic review of qualitative studies

    Eriksen, C. U., Kyriakidis, S., Christensen, L. D., Jacobsen, Ramune, Laursen, J. T. E., Christensen, Mikkel Bring & Frølich, Anne, 2020, In: International Journal of Integrated Care. 20, Supplement 1, 3 p., A61.

    Research output: Contribution to journal › Conference article › Research › peer-review

  23. Published

    Prevalence of polypharmacy in Denmark

    Kornholt, J. & Christensen, Mikkel Bring, 2020, In: Danish Medical Journal. 67, 6, p. 1-5 5 p., A12190680.

    Research output: Contribution to journal › Journal article › Research › peer-review

  24. Published

    Sex and age differences among tramadol users in three Nordic countries

    Schelde, Astrid Blicher, Sorensen, A. M. S., Hindsø, M., Christensen, Mikkel Bring, Jimenez-Solem, E. & Eriksson, R., 2020, In: Danish Medical Journal. 67, 7, 12 p., A06190336.

    Research output: Contribution to journal › Journal article › Research › peer-review

  25. Published

    Six-day subcutaneous GIP infusion increases glycaemic time in range in patients with type 1 diabetes

    Heimbuerger, S. M. N., Hoe, B., Nielsen, C. N., Bergmann, N. C., Hartmann, Bolette, Holst, Jens Juul, Størling, Joachim, Vilsbøll, Tina, Dejgaard, T. F., Christensen, Mikkel Bring & Knop, Filip Krag, 2020, In: Diabetologia. 63, SUPPL 1, p. S73 1 p., 145.

    Research output: Contribution to journal › Conference abstract in journal › Research

  26. Published

    Systemisk toksicitet ved lokalanalgetika

    Johansson, K. S., Høgberg, L. C. G., Christensen, Mikkel Bring, Petersen, Tonny Studsgaard, Dalhoff, Kim & Bøgevig, S., 2020, In: Ugeskrift for Laeger. 182, 51, 6 p., V11190656.

    Research output: Contribution to journal › Journal article › Research › peer-review

  27. Published

    The role of endogenous GIP and GLP-1 in postprandial bone homeostasis

    Helsted, M. M., Gasbjerg, Lærke Smidt, Lanng, A. R., Bergmann, N. C., Stensen, S., Hartmann, Bolette, Christensen, Mikkel Bring, Holst, Jens Juul, Vilsbøll, Tina, Rosenkilde, Mette & Knop, Filip Krag, 2020, In: Bone. 140, 7 p., 115553.

    Research output: Contribution to journal › Journal article › Research › peer-review

  28. Published

    Two-bag intravenous N-acetylcysteine, antihistamine pretreatment and high plasma paracetamol levels are associated with a lower incidence of anaphylactoid reactions to N-acetylcysteine

    Daoud, A., Dalhoff, Kim, Christensen, Mikkel Bring, Bøgevig, S. & Petersen, Tonny Studsgaard, 2020, In: Clinical Toxicology. 58, 7, p. 698-704

    Research output: Contribution to journal › Journal article › Research › peer-review

  29. Published

    What is on the horizon for type 2 diabetes pharmacotherapy? - An overview of the antidiabetic drug development pipeline

    Johansson, K. S., Sonne, D., Knop, Filip Krag & Christensen, Mikkel Bring, 2020, In: Expert Opinion on Drug Discovery. 15, 11, p. 1253-1265

    Research output: Contribution to journal › Review › Research › peer-review

ID: 96275756